Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement from the American Heart Association and American College of Cardiology

Circulation

Volumn 132, Issue 22, 2015, Pages e256-e261

  Maron, Barry J ^a   Zipes, Douglas P ^b   Kovacs, Richard J ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

AHA Scientific Statements; athletes; cardiovascular abnormalities; genetics; hypertrophic cardiomyopathy; sudden death

Indexed keywords

ARTICLE; ATHLETE; CARDIAC PATIENT; CARDIOVASCULAR MALFORMATION; CAUSE OF DEATH; HUMAN; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SPORTS MEDICINE; SUDDEN DEATH; ADVISORY COMMITTEE; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; DEATH, SUDDEN, CARDIAC; ORGANIZATION; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; ATHLETES; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; CONGRESSES AS TOPIC; DEATH, SUDDEN, CARDIAC; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84949321889     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000236     Document Type: Article

References (19)

1. Mitchell JH, Maron BJ, Epstein SE. 16th Bethesda Conference: cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition: October 3-5, 1984. J Am Coll Cardiol. 1985;6:1186-1232.
2. Maron BJ, Mitchell JH. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities [published correction appears in Med Sci Sports Exerc. 1994;26:followi]. J Am Coll Cardiol. 1994;24:845-899.
3. Maron BJ, Zipes DP. 36th Bethesda Conference: introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1318-1321. doi: 10.1016/j. jacc.2005.02.006.
4. Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD; on behalf of American Heart Association Council on Clinical Cardiology; Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; Council on Quality of Care and Outcomes Research, and American College of Cardiology. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation. 2014;130:1303-1334. doi: 10.1161/CIR.0000000000000025.
5. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064-1075. doi: 10.1056/NEJMra022783.
6. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092. doi: 10.1161/CIRCULATIONAHA.108.804617.
7. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 1996;276:199-204.
8. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593-1601. doi: 10.1001/jama.296.13.1593.
9. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araújo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP; for the Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807-2816. doi: 10.1161/01.CIR.0000128363.85581.E1.
10. Maron BJ, Estes NA 3rd. Commotio cordis. N Engl J Med. 2010;362:917-927. doi: 10.1056/NEJMra0910111.
11. Maron BJ, Barry JA, Poole RS. Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety. Am J Cardiol. 2004;93:441-444. doi: 10.1016/j.amjcard.2003.10.038.
12. Harris KM, Sponsel A, Hutter AM Jr, Maron BJ. Brief communication: cardiovascular screening practices of major North American professional sports teams. Ann Intern Med. 2006;145:507-511.
13. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy [published correction appears in Circulation. 2010;122:e7]. Circulation. 2010;121:445-456. doi: 10.1161/CIRCULATIONAHA.109.878579.
14. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61:1527-1535. doi: 10.1016/j. jacc.2013.01.037.
15. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverterdefibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [published correction appears in JAMA. 2007;298:1516]. JAMA. 2007;298:405-412. doi: 10.1001/jama.298.4.405.
16. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011;58:1485-1496. doi: 10.1016/j.jacc.2011.06.043.
17. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-1963.
18. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine [published correction appears in J Am Coll Cardiol. 2014;64:1188]. J Am Coll Cardiol. 2014;64:83-99. doi: 10.1016/j.jacc.2014.05.003.
19. Maron BJ, Mitten MJ, Quandt EF, Zipes DP. Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med. 1998;339:1632-1635. doi: 10.1056/NEJM199811263392211.